BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33986873)

  • 1. Differentiation-related zinc finger protein 750 suppresses cell growth in esophageal squamous cell carcinoma.
    Ana Choi SS; Ko JM; Yu VZ; Ning L; Lung ML
    Oncol Lett; 2021 Jul; 22(1):513. PubMed ID: 33986873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of
    Nambara S; Masuda T; Tobo T; Kidogami S; Komatsu H; Sugimachi K; Saeki H; Oki E; Maehara Y; Mimori K
    Oncol Lett; 2017 Aug; 14(2):1795-1801. PubMed ID: 28789412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Function and mechanism of zinc finger protein ZNF50 in inhibiting the growth of esophageal squamous cell carcinoma cells].
    Wang J; Bi YH; Yang J; Liu F; Li YK; Cui HY; Wang F; Liu J; Yang B; Zhang L
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):7-12. PubMed ID: 28104026
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC.
    Kong P; Xu E; Bi Y; Xu X; Liu X; Song B; Zhang L; Cheng C; Yan T; Qian Y; Yang J; Ma Y; Cui H; Zhai Y; Zou B; Liu X; Cheng Y; Guo S; Cheng X; Cui Y
    Theranostics; 2020; 10(4):1798-1813. PubMed ID: 32042337
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma.
    Zhang L; Niu X; Bi Y; Cui H; Li H; Cheng X
    Technol Cancer Res Treat; 2020; 19():1533033820948060. PubMed ID: 32924793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma.
    Otsuka R; Akutsu Y; Sakata H; Hanari N; Murakami K; Kano M; Toyozumi T; Takahashi M; Matsumoto Y; Sekino N; Yokoyama M; Okada K; Shiraishi T; Komatsu A; Iida K; Matsubara H
    Oncology; 2018; 94(3):142-148. PubMed ID: 29216641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZNF750 Expression as a Novel Candidate Biomarker of Chemoradiosensitivity in Esophageal Squamous Cell Carcinoma.
    Otsuka R; Akutsu Y; Sakata H; Hanari N; Murakami K; Kano M; Takahashi M; Matsumoto Y; Sekino N; Yokoyama M; Iida K; Matsubara H
    Oncology; 2017; 93(3):197-203. PubMed ID: 28558382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
    Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
    J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of tumor suppressor gene ZNF750 inhibits oral squamous cell carcinoma metastasis.
    Yang H; Pan L; Xu C; Zhang Y; Li K; Chen S; Zhang B; Liu Z; Wang LX; Chen H
    Oncol Lett; 2017 Nov; 14(5):5591-5596. PubMed ID: 29113187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma.
    Hazawa M; Lin DC; Handral H; Xu L; Chen Y; Jiang YY; Mayakonda A; Ding LW; Meng X; Sharma A; Samuel S; Movahednia MM; Wong RW; Yang H; Tong C; Koeffler HP
    Oncogene; 2017 Apr; 36(16):2243-2254. PubMed ID: 27819679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased ZNF750 promotes angiogenesis in a paracrine manner via activating DANCR/miR-4707-3p/FOXC2 axis in esophageal squamous cell carcinoma.
    Bi Y; Guo S; Xu X; Kong P; Cui H; Yan T; Ma Y; Cheng Y; Chen Y; Liu X; Zhang L; Cheng C; Xu E; Qian Y; Yang J; Song B; Li H; Wang F; Hu X; Liu X; Niu X; Zhai Y; Liu J; Li Y; Cheng X; Cui Y
    Cell Death Dis; 2020 Apr; 11(4):296. PubMed ID: 32341351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma.
    Zhang L; Zhou Y; Cheng C; Cui H; Cheng L; Kong P; Wang J; Li Y; Chen W; Song B; Wang F; Jia Z; Li L; Li Y; Yang B; Liu J; Shi R; Bi Y; Zhang Y; Wang J; Zhao Z; Hu X; Yang J; Li H; Gao Z; Chen G; Huang X; Yang X; Wan S; Chen C; Li B; Tan Y; Chen L; He M; Xie S; Li X; Zhuang X; Wang M; Xia Z; Luo L; Ma J; Dong B; Zhao J; Song Y; Ou Y; Li E; Xu L; Wang J; Xi Y; Li G; Xu E; Liang J; Yang X; Guo J; Chen X; Zhang Y; Li Q; Liu L; Li Y; Zhang X; Yang H; Lin D; Cheng X; Guo Y; Wang J; Zhan Q; Cui Y
    Am J Hum Genet; 2015 Apr; 96(4):597-611. PubMed ID: 25839328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZNF750 inhibited the malignant progression of oral squamous cell carcinoma by regulating tumor vascular microenvironment.
    Pan L; Yang H; Xu C; Chen S; Meng Z; Li K; Chen H
    Biomed Pharmacother; 2018 Sep; 105():566-572. PubMed ID: 29890464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.
    Yoshioka M; Ohashi S; Ida T; Nakai Y; Kikuchi O; Amanuma Y; Matsubara J; Yamada A; Miyamoto S; Natsuizaka M; Nakagawa H; Chiba T; Seno H; Muto M
    J Exp Clin Cancer Res; 2017 Aug; 36(1):101. PubMed ID: 28764725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral heterogeneity of esophageal squamous cell carcinoma and its clinical significance.
    Wang X; Jia Y; Deng H; Liu Y; Liu Y
    Pathol Res Pract; 2019 Feb; 215(2):308-314. PubMed ID: 30528923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol suppresses malignant progression of oral squamous cell carcinoma cells by inducing the ZNF750/RAC1 signaling pathway.
    Xiao Y; Duan Y; Wang Y; Yin X
    Bioengineered; 2021 Dec; 12(1):2863-2873. PubMed ID: 34176441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
    Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF750 exerted its Antitumor Action in Oral Squamous Cell Carcinoma by regulating E2F2.
    Yang HL; Xu C; Yang YK; Tang WQ; Hong M; Pan L; Chen HY
    J Cancer; 2021; 12(24):7266-7276. PubMed ID: 35003347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.